Pan, Lizhen
Bigalke, Hans
Kopp, Bruno
Jin, Lingjing
Dressler, Dirk
Funding for this research was provided by:
National Key R&D Program of China ((2018YFC1314700))
National Natural Science Foundation of China (81500970, 81500970)
Shanghai Hospital Development Center ((16CR3009A).)
National Key R&D Program of China (2018YFC1314700)
Shanghai Hospital Development Center (16CR3009A)
Article History
Received: 13 August 2019
Accepted: 25 October 2019
First Online: 9 November 2019
Compliance with ethical standards
:
: DD received honoraria for consultations from Allergan, Ipsen, IAB-Interdisciplinary Working Group for Movement Disorders, Merz and Syntaxin. He is a shareholder of Allergan. He holds patents in botulinum toxin research and provides professional consulting services to pharmaceutical companies and professional investment institutions on all aspects of botulinum toxin drugs. HB is the founder and co-owner of Toxogen. LP, BK and LJ have nothing to disclose.